APR-002
- Generic Name
- APR-002
SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects
- First Posted Date
- 2022-03-07
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Global Health Drug Discovery Institute
- Target Recruit Count
- 42
- Registration Number
- NCT05268198
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath